Best Nursing Ce Podcasts (2024)

1
Ethical Considerations in Medical Error Communication Episode 1 32:55

8d ago32:55

32:55

This is episode 1 of the series: Ethical Considerations in Medical Error Communication. Join this podcast course as it explores the ethics of revealing medical errors to patients and families, uncovering the impact on trust and relationships. Discover the advantages of open communication and the hurdles healthcare providers face when admitting mist…

1
Multiple Myeloma Care: Translating Evolving Practices to Oncology Nurses in Community Settings

12d ago

—

Host: Jennifer Caudle, DO Guest: Patricia A. Mangan, RN, MSN, APRN-BC The expansion of treatment options and strategies across the disease continuum is good news for patients who previously had few options; however, it can be a challenge for clinicians to stay up–to date in this very dynamic setting.…

1
Optimizing Biomarker Testing to Guide Treatment Selection for Metastatic Colorectal Cancer

24h ago

—

Guest: Elizabeth Montgomery, MD Guest: John L. Marshall, MD This 1.0-credit activity provides oncology clinicians with practical insights into the importance of biomarker testing in patients diagnosed with metastatic colorectal cancer (mCRC), optimizing biomarker testing procedures, and the role of biomarkers in guiding treatment selection. Case vi…

1
Optimizing Biomarker Testing to Guide Treatment Selection for Metastatic Colorectal Cancer

24h ago

—

Guest: Elizabeth Montgomery, MD Guest: John L. Marshall, MD This 1.0-credit activity provides oncology clinicians with practical insights into the importance of biomarker testing in patients diagnosed with metastatic colorectal cancer (mCRC), optimizing biomarker testing procedures, and the role of biomarkers in guiding treatment selection. Case vi…

1
Emerging Frontiers: CAR T-Cell Therapy for Solid Tumors in Thyroid Cancer

24h ago

—

Host: Matt Birnholz, MD Guest: Saad Kenderian M.B, Ch.B CAR T-cell therapy has been revolutionary in the treatment of blood cancers like chronic lymphocytic leukemia and multiple myeloma, and according to recent research, this therapeutic approach may also help patients with thyroid cancer. However, there are several challenges associated with appl…

1
Navigating IgA Nephropathy: Insights From a Patient With Lived Experience 21:53

2d ago21:53

21:53

In this CCO Nephrology podcast episode, hear from Kelly Chen, a nephrology nurse practitioner and patient living with IgA nephropathy, as she discusses her experiences with Dr Pietro Canetta, Associate Professor of Medicine at Columbia University and expert in glomerular diseases. Episode outline: Seeking and obtaining an IgAN diagnosis Patient sel…

1
MCED Testing: Confirming a Positive Result with Diagnostic Follow-Up

2d ago

—

Host: Brian P. McDonough, MD, FAAFP Guest: Betsy O'Donnell, MD Guest: Tomasz Beer, MD, FACP Should a patient get a positive multi-cancer early detection (MCED) test result, there are two diagnostic resolution pathways proposed for localizing and confirming that result. Joining Dr. Brian McDonough to break down those two pathways and how we can opti…

1
Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies

7d ago

—

Host: Perry Shieh, MD, PhD Explore this on-demand webcast for an in-depth expert presentation and case discussion. This educational initiative is designed to help neurologists enhance their clinical approach by providing individualized, evidence-based care for adult SMA patients. Gain insights into the latest treatment options, safety and efficacy …

1
Dual Challenges: Managing Hepatocellular Carcinoma with Hepatitis B Co-Infection

4d ago

—

Host: Jody Takemoto, PhD Guest: Robert Wong, MD Hepatitis B is one of the leading causes of liver cancer globally, underscoring the importance of screening, diagnosing, and treating patients appropriately. However, there are several considerations to keep in mind when caring for patients with hepatocellular carcinoma with hepatitis B co-infection, …

1
Current Updates in Brain Imaging and Neurodegenerative Diseases

4d ago

—

Guest: Phillip H. Kuo, MD, PhD One of the major changes that's occurred very recently in the field of neurodegenerative disease and Alzheimer's disease, specifically, are the recently approved antibody therapies that remove amyloid from the brain, which is one of the culprit proteins in Alzheimer's disease. To learn more about this presentation fro…

1
Ethical Considerations in Medical Error Communication Episode 2 32:05

8d ago32:05

32:05

This is episode 2 of the series: Ethical Considerations in Medical Error Communication. Join this podcast course as it explores the ethics of revealing medical errors to patients and families, uncovering the impact on trust and relationships. Discover the advantages of open communication and the hurdles healthcare providers face when admitting mist…

1
Uncovering Barriers to HCC Surveillance in Patients with Cirrhosis

10d ago

—

Host: Jody Takemoto, PhD Guest: Robert Wong, MD A recent study explored clinician-level gaps and barriers to hepatocellular carcinoma surveillance in patients with cirrhosis and found that there is a lot of work to be done to help improve knowledge about cirrhosis, the recommended cancer screening guidelines, and how to implement those recommendati…

1
Multiple Myeloma Care: Translating Evolving Practices to Oncology Nurses in Community Settings

12d ago

—

Host: Jennifer Caudle, DO Guest: Patricia A. Mangan, RN, MSN, APRN-BC The expansion of treatment options and strategies across the disease continuum is good news for patients who previously had few options; however, it can be a challenge for clinicians to stay up–to date in this very dynamic setting.…

1
A Look at the Utility of PSMA PET Scans in Prostate Cancer

12d ago

—

Host: Jennifer Caudle, DO Guest: Geoffrey B. Johnson, M.D., Ph.D. Prostate-specific membrane antigen (PSMA) PET scans are a method by which clinicians can see if a patient who is suffering from prostate cancer has tumors that are expressing the PSMA target. In addition to that, the scan allows us to measure how much of the medication we get onto th…

1
Salivary Toxicity from PSMA-Targeted Radiopharmaceuticals in mCRPC

13d ago

—

Guest: Geoffrey B. Johnson, M.D., Ph.D. When looking at patients who suffer from prostate cancer who are receiving PSMA therapy, we can see on our images that the medication not only goes to their cancer, but it also goes to some other things in their body, including the salivary glands. To learn more about his recent study on salivary toxicity, jo…

1
CME/CE Podcast: Impacting COPD Outcomes – Challenges and Opportunities 15:59

16d ago15:59

15:59

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit: https://www.mycme.com/courses/impacting-copd-outcomes-challenges-and-opportunities-9534 Summary Join Dr. Fernando Martinez as he welcomes Dr. David Au and Dr. Jamuna Krishnan to The NACE Clinical Highlights Show. Th…

1
CME/CE Deep Dive into 5: Your Questions on Menopausal Vasomotor Symptoms 14:53

15d ago14:53

14:53

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit: https://www.mycme.com/courses/dd5-your-questions-on-menopausal-vasomotor-symptoms-9542 Summary Dr. Leana Wen guides Dr. Genevieve Neal-Perry through five of your most common questions on menopausal VMS. Get a better…

1
CME/CE Podcast: A Better Understanding: Advances in Severe Asthma 14:11

16d ago14:11

14:11

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit: https://www.mycme.com/courses/a-better-understanding-advances-in-severe-asthma-9530 Summary In this CME/CE podcast, join NACE and the Association for Pulmonary Advanced Practice Providers as Nurse Practitioner Corin…

1
The Evolving AI Landscape in Nuclear Medicine

16d ago

—

Guest: Joyita Dutta The AI landscape is evolving at a rapid pace. However, there is a shortage of large public data sets in nuclear medicine that AI models can be trained on. To learn more about what’s on the AI horizon and the challenges that are associated, join Dr. Joyita Dutta, Associate Professor at the University of Massachusetts, Amherst in …

1
Diving into New Directions of Radiopharmaceuticals

16d ago

—

Guest: Brianna Cagle The Discovery Team at Perspective has developed a compound, called PSV-359, which is a cyclic peptide radiopharmaceutical. It targets a protein, called fibroblast activation protein (FAP), which is a pan-cancer target and is expressed in a wide variety of cancers. To learn more about her presentation from SNMMI 2024, hear from …

1
AI in Nuclear Medicine: Improvements in the Field

16d ago

—

Guest: Chi Liu, PhD The field of artificial intelligence in nuclear medicine is evolving quickly with new models and approaches. Tune in with Dr. Chi Liu, Professor of Radiology and Biomedical Engineering at Yale University, to hear more about his presentation from SNMMI 2024.

1
Highlighting the Current Status and Future of Theranostics

16d ago

—

Guest: Geoffrey B. Johnson, M.D., Ph.D. Clinicians are hopeful that theranostics could help treat patients as soon as they go metastatic or even before surgery to try to affect their therapy and possibly get them to avoid having to take toxic or high side effect therapies. To hear more, tune in with Dr. Geoffrey Johnson, Nuclear Medicine Specialist…

1
CME/CE PODCAST: Recognizing the Burden of Residual Symptoms in MDD 29:39

17d ago29:39

29:39

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit: https://www.mycme.com/courses/recognizing-the-burden-of-residual-symptoms-in-mdd-9526 Summary Early and effective treatment of major depressive disorder (MDD) is essential to prevent persistent residual symptoms, wh…

1
Health Literacy: Bridging the Language Gap Episode 2 34:48

23d ago34:48

34:48

This is episode 2 of the series: Health Literacy: Bridging the Language Gap. Episode 2: Explore strategies for enhancing health literacy and overcoming barriers in healthcare. Discover the significance of assessing health literacy during patient interactions and adopting system-level approaches to promote a health literate healthcare organization. …

1
Health Literacy: Bridging the Language Gap Episode 1 30:47

23d ago30:47

30:47

This is episode 1 of the series: Health Literacy: Bridging the Language Gap. Episode 1: Delve into the critical importance of health literacy and the challenges encountered by those with low literacy skills. This podcast emphasizes the profound impact of inadequate health literacy on healthcare outcomes and underscores the crucial role nurses play …

1
MCED Testing: Strategies for Mitigating the Risk of Overdiagnosis

24d ago

—

Host: Brian P. McDonough, MD, FAAFP Guest: Nima Nabavizadeh, MD Guest: Tomasz Beer, MD, FACP While multi-cancer early detection (MCED) testing has the potential to significantly impact the way we approach cancer screening, it’s important to be aware of the risks associated with it, like overdiagnosis. That’s why Drs. Nima Nabavizadeh and Tom Beer j…

1
A Unique Look at the Current and Future Directions of Cancer Vaccines

24d ago

—

Guest: Lillian Siu, MD, FRCPC Since cancer vaccines have been of interest to oncologists for decades, they’ve been trying to figure out how to prime or stimulate the immune system to attack cancer, and until the last few years, cancer vaccines have been challenging. To learn about this unique area of study, which she also presented at ASCO 2024, jo…

1
A Look at the Horizon of Cancer Vaccines

24d ago

—

Guest: Lillian Siu, MD, FRCPC With a few studies in the works for cancer vaccines, the future is exciting for what this could mean for oncology patients. Dive in to learn about the various ways to package cancer vaccines so they can be delivered to patients effectively. And to learn more about the limitations, targets, and platforms of cancer vacci…

1
Practice Changing Highlights in G/GEJ Cancers: The Latest Data from Chicago

27d ago

—

Host: Samuel J. Klempner, MD The therapeutic landscape for gastric and gastroesophageal junction (G/GEJ) cancer is rapidly evolving, with biomarkers directing treatment selection. Recent evidence suggests that the combination of HER2-targeted therapies and immune checkpoint inhibitors has synergistic effects, highlighting the importance of the most…

1
Implementing a Successful Barostim Program in the Clinic: Best Practices and Real World Experience

26d ago

—

Guest: Jessica Griffiths, PA-C Guest: Anna L. Rourke, NP The BeAT-HF clinical trial showed that Barostim plus GDMT resulted in significant and meaningful improvements in exercise capacity, functional status, and quality of life. Learn best practices from advanced practice providers for successfully integrating Barostim into your clinical practice.…

1
CME/CE Deep Dive into 5: Answering Your Questions on Lipids and Risk 13:26

30d ago13:26

13:26

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit: https://www.mycme.com/courses/answering-your-questions-on-lipids-and-risk-9498 Summary There’s no shortage of information on the management of lipids for the prevention of cardiovascular disease: 2018 Guideline on t…

1
Updates on New Technologies and Imaging Agents in Healthcare

30d ago

—

Guest: Tyler J Bradshaw, PhD In recent years, doctors have become interested in how large language models and AI technologies could potentially improve radiology overall. Even though these technologies are still in the beginning stages of being used in medicine, eventually doctors hope to show what impact they could have on patients. To learn more …

1
The Power of Patient Advocacy in Daily Clinical Practice

30d ago

—

Guest: Ashley L. Sumrall, MD Advocacy is rooted in patients telling their stories, and every patient can be an advocate to help and allow others to hear about their experience. This has also helped clinicians get the medicine they need for their patients. Dive in to hear how you can incorporate advocacy strategies into your practice with Dr. Ashley…

1
The Impact of Advocacy on Healthcare

30d ago

—

Guest: Ashley L. Sumrall, MD If we want to ensure that we and our patients have healthcare when we’re older and it continues to be available, it’s important to take a stand and be a part of advocacy work. There are multiple ways to get involved, and it’s not as intimidating as someone might think, so to share some of these strategies and the impact…

1
Practical Applications for Quality Improvement in Myelofibrosis Management: A Video Brief on Lessons Learned

1M ago

—

Host: Joseph Kim, MD, MPH This video brief will discuss quality improvement in myelofibrosis management. To highlight ways to improve care for patients with both primary and secondary myelofibrosis, we’ll examine the experiences of two cancer centers that engaged in quality improvement programs. Molecular Testing Symptom Assessment Prognostic Risk …

1
The Role of Nurse Navigators in Healthcare: Episode 1 29:59

1M ago29:59

29:59

This is episode 1 of the series: The Role of Nurse Navigators in Healthcare. Episode 1: Explore the crucial role of nurse navigators in today's healthcare landscape. Delve into the various aspects of patient care coordination, from oncology to chronic conditions, and discover how nurse navigators provide essential support, education, and communicat…

1
The Role of Nurse Navigators in Healthcare: Episode 2 35:28

1M ago35:28

35:28

This is episode 2 of the series: The Role of Nurse Navigators in Healthcare. Episode 2: Discover the pivotal role of nurse navigators in modern healthcare in this insightful episode. Uncover the challenges they face and the invaluable contributions they make to patient care. Learn how nurse navigators coordinate care, provide crucial support, and s…

1
Improving Adherence and Persistence With Durable Anti-VEGF Therapies for nAMD

1M ago

—

Host: Diana V. Do, MD Guest: Peter K. Kaiser, MD This case consult with Dr Do and Dr Kaiser will consider a treatment-experienced patient referred for a 2nd opinion with decreased vision and prior diagnosis of neovascular AMD (nAMD). Dr Do and Dr Kaiser will discuss the recently approved anti-vascular endothelial growth factor (VEGF) agents with gr…

1
A Pre-Conference Perspective of SNMMI 2024

1M ago

—

Tune in ahead of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2024 Annual Meeting in Toronto for a preview of what to expect with Dr. Munir Ghesani, Chief Medical Officer and the Medical Director at United Theranostics in Princeton, New Jersey.

1
An Introduction to Squamous Cell Carcinoma of the Head and Neck

1M ago

—

Guest: Lori J. Wirth, MD Head and neck cancers are the seventh most common cancers globally and are increasing in prevalence.1,2 To dive further into the intricacies of this early-stage cancer, join Dr. Lori Wirth, Medical Oncologist in the Head and Neck Oncology Program at Massachusetts General Hospital in Boston. References: Gormley M, et al. Br …

1
CME/CE Deep Dive into 5: Answering Your Questions on Asthma Biologics 14:30

1M ago14:30

14:30

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit: https://www.mycme.com/courses/dd5-answering-your-questions-on-asthma-biologics-9499 Summary In this activity, our asthma faculty, Dr. Diego Maselli, tackle the common, learner-submitted questions about the use of bi…

1
CME/CE Deep Dive into 5: Your Questions on Cytokines in Asthma 17:49

1M ago17:49

17:49

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit: https://www.mycme.com/courses/dd5-your-questions-on-cytokines-in-asthma-9477 Summary In this activity, moderator Corinne Young works with asthma expert Amanda Michaud to answer the common and remaining questions reg…

1
The APAPP Podcast Ep.12: Biologics in COPD: Why, When, and Who 23:15

2M ago23:15

23:15

NACE is excited to provide you with this podcast episode from our educational collaborator, The Association of Pulmonary Advanced Practice Providers (APAPP). APAPP is the first association of Advanced Practice Providers (APPs), both Nurse Practitioners and Physician Assistants, who work in the field of pulmonary medicine. APAPP's mission is to work…

1
EMERALD Trial: An Analysis of Key Biomarkers and Patient Subgroups

2M ago

—

Host: Jennifer Caudle, DO Guest: Joyce O'Shaughnessy, MD The results from the phase III EMERALD trial led to the approval of ORSERDU® (elacestrant) as the first oral selective estrogen receptor degrader for ER-positive/HER2-negative metastatic breast cancer patients with ESR1 mutations after disease progression following at least one line of endocr…

1
CD20 X CD3 Bispecifics—Redefining Treatment for Patients with R/R DLBCL/LBCL in the Community Setting

2M ago

—

Host: Matthew Lunning, DO, FACP In the rapidly evolving landscape of treating patients with relapsed or refractory large/diffuse large B-cell lymphoma (R/R LBCL/DLBCL), recent advancements are providing newfound hope. Immunochemotherapy with R-CHOP has long been the standard first-line treatment, but a significant portion of patients experience rel…

1
Evolving Our View of the Coagulation Cascade and Stroke Management

2M ago

—

Host: Valeria Caso, MD, PhD Guest: Ashkan Shoamanesh, MD How can you improve long-term secondary stroke prevention in patients with a history of noncardioembolic ischemic stroke or transient ischemic attack (TIA)? An understanding of how to apply emerging clinical trial data is critical, as is the evaluation of potential alternative agents that cou…

1
Consensus Recommendations for Use of p16/Ki67 Dual Staining Cytology in the Management of Individuals Testing Positive for HPV

2M ago

—

Host: Warner K. Huh, MD Guest: Kimberly Levinson, MD, MPH More effective triage tests are essential to improving cervical cancer risk-stratification and thus reducing the potential for unnecessary colposcopies. Enduring consensus cervical cancer screening recommendations, published in 2024, describe specific-use algorithms for p16/Ki-67 dual-staini…

1
Nursing Preceptorship: Cultivating Competence: Episode 1 31:15

2M ago31:15

31:15

This is episode 1 of the series: Nursing Preceptorship: Cultivating Competence. Episode 1: In this episode, delve into the nuances of preceptorship versus mentorship, highlighting how preceptorship verifies clinical competence for specific roles, while mentorship nurtures professional and personal growth. Discover the vital role effective preceptor…

1
Nursing Preceptorship: Cultivating Competence: Episode 2 38:32

2M ago38:32

38:32

This is episode 2 of the series: Nursing Preceptorship: Cultivating Competence. Episode 2: This episode delves into practical tools and strategies for nursing preceptors, tackling challenges like addressing performance issues and maintaining work-life balance. Emphasizing clear communication and problem-solving skills, the importance of cultural co…

1
Poster Pearl: A 2-Biomarker Class MCED Test Delivers High Specificity and Sensitivity

2M ago

—

Host: Brian P. McDonough, MD, FAAFP Guest: Frank Diehl, PhD A poster presented at the 2024 American Association for Cancer Research Annual Meeting showcased findings from the ASCEND 2 study, which examined the performance of a multi-cancer early detection (MCED) test design that included methylation and protein biomarkers. The study found that this…

Podcasts Worth a Listen

Nursing Ce Podcasts

Podcasts Worth a Listen

Quick Reference Guide